ASG-22CE

DRUG2 trials

Sponsors

Astellas Pharma Inc, Kyoto University Hospital

Conditions

Bladder CancerMedical OncologyNeoplasmsTumors

Phase 1

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

CompletedNCT01409135

Astellas Pharma IncMedical Oncology, Neoplasms, Tumors

Start: 2011-07-11End: 2015-04-27Updated: 2024-03-12

Phase 2

Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)

RecruitingNCT05879653

Kyoto University HospitalBladder Cancer

Start: 2023-10-01End: 2027-09-30Target: 30Updated: 2025-08-29